This is a firm fixed price delivery order contract awarded by the Veterans Integrated Service Network 16 (VISN 16), part of the U.S. Department of Veterans Affairs, to Veracyte, Inc., a for-profit provider of genomic testing services. The contract is for thyroid testing services, with a ceiling value of $165,200.00 and a period of performance through April 30, 2026. Veracyte has provided similar laboratory testing services to the Department of Defense and Veterans Affairs in the past, using genomic classifiers to support cancer detection and diagnosis, as well as differentiation of lung diseases. This order is part of a larger Indefinite Delivery Indefinite Quantity (IDIQ) contract vehicle that Veracyte holds with VISN 23, valued at up to $600,000 through April 2028, enabling the VA to efficiently access Veracyte's commercial laboratory capabilities. The contract does not have a set-aside designation.
Generated 1/29/25, 9:29 AM